Whereas anti-TNF antibodies are used to cure irAEs associated with immunotherapies (such as anti-CTLA-4, anti-PD-1 or a combination of both)24, whether TNF blockade affects the anti-melanoma immune response triggered by immunotherapies remains to be determined. The gene discussed is CTLA4; the disease is melanoma.